The National Health Service (NHS) has recommended Bayer HealthCare’s oral anticoagulant Xarelto (rivaroxaban) for use in final guidance by the United Kingdom’s National Institute for Health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results